Your browser doesn't support javascript.
loading
Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation.
Miyamura, Koichi; Ohnishi, Kazunori; Ohtake, Shigeki; Usui, Noriko; Nakaseko, Chiaki; Fujita, Hiroyuki; Fujisawa, Shin; Sakura, Toru; Okumura, Hirokazu; Iriyama, Noriyoshi; Emi, Nobuhiko; Fujimaki, Katsumichi; Honda, Sumihisa; Miyazaki, Yasushi; Naoe, Tomoki.
Afiliación
  • Miyamura K; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Ohnishi K; Tokai-Hokuriku Block Blood Center, Seto, Japan.
  • Ohtake S; Kanazawa University, Kanazawa, Japan.
  • Usui N; Department of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
  • Nakaseko C; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Fujita H; Department of Hematology, International University of Health and Welfare, Narita, Japan.
  • Fujisawa S; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan.
  • Sakura T; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Okumura H; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Iriyama N; Department of Hematology, Toyama Prefecture Center Hospital, Toyama, Japan.
  • Emi N; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Fujimaki K; Department of Hematology, Fujita Health University, Toyoake, Japan.
  • Honda S; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan.
  • Miyazaki Y; Department of Nursing, Nagasaki University, Nagasaki, Japan.
  • Naoe T; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan; and.
Blood Adv ; 3(3): 312-319, 2019 02 12.
Article en En | MEDLINE | ID: mdl-30705033
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos